• In late June 2026, Veeva Systems Inc. (NYSE:VEEV) was removed from multiple Russell growth and defensive benchmarks, including the Russell 1000 Growth and Russell Midcap Growth indices.
• Around the same time, Veeva introduced Veeva EHS within its Quality Cloud, extending its platform into environmental, health, and safety workflows that link directly with existing quality and training tools.
• Next, we will examine how the launch of Veeva EHS could reshape Veeva’s investment narrative around integrated cloud workflows and automation.

Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Veeva Systems Investment Narrative Recap

To own Veeva, you need to believe in its role as a core cloud platform for life sciences workflows, from R&D to manufacturing and quality. The key near term catalyst remains execution on integrated AI and automation across Vault, while major risks center on competitive pressure from larger software vendors and customer hesitation around adopting new tools. The recent Russell index removals look more like a technical reclassification than something that changes these fundamentals in a material way.

Against that backdrop, the launch of Veeva EHS inside Quality Cloud is especially relevant. It extends Veeva deeper into environmental, health, and safety processes and ties directly into Quality Management and Training so a single incident can trigger deviations and retraining automatically. This fits squarely with the core catalyst of broader, integrated cloud workflows and automation, but it will still need to overcome customer change fatigue and proof of real productivity gains at scale.

Yet even if EHS and AI agents gain traction, investors should still be aware of the risk that large pharma customers gain more pricing power and...

Veeva Systems' narrative projects $4.7 billion revenue and $1.4 billion earnings by 2029. This requires 12.4% yearly revenue growth and an earnings increase of about $0.5 billion from $941.7 million today.

Uncover how Veeva Systems' forecasts yield a $245.48 fair value, a 30% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were assuming Veeva could reach about US$5,000,000,000 in revenue and US$1,600,000,000 in earnings by 2029, which is far more bullish than the consensus narrative. In light of the index removals and new products such as Veeva EHS, you can see how views might shift, especially if you also consider how much these same analysts were counting on AI agents and faster adoption in areas like Development Cloud to justify higher valuations and margins.

Explore 9 other fair value estimates on Veeva Systems - why the stock might be worth as much as 70% more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Veeva Systems research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free Veeva Systems research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Veeva Systems' overall financial health at a glance.

Want Some Alternatives?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Find 44 companies with promising cash flow potential yet trading below their fair value.
• Uncover the next big thing with 20 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.